Immune function monitoring in lung transplantation using adenosine triphosphate production: time trends and relationship to postoperative infection
- PMID: 27853868
- DOI: 10.1007/s00595-016-1440-3
Immune function monitoring in lung transplantation using adenosine triphosphate production: time trends and relationship to postoperative infection
Abstract
Purpose: The ImmuKnow (IK) assay is a comprehensive immune function test that involves measuring adenosine triphosphate produced by the cluster of differentiation 4+ T lymphocytes in peripheral blood. The aim of this study was to analyze the time trends of IK values and assess the relationship between IK values and infections in lung transplants.
Methods: We prospectively collected 178 blood samples from 22 deceased-donor lung transplant (DDLT) recipients and 17 living-donor lobar lung transplant (LDLLT) recipients. A surveillance IK assay was performed postoperatively, then after 1 week and 1, 3, 6, and 12 months.
Results: Time trends of IK values in stable recipients peaked 1 week after DDLT (477 ± 247 ATP ng/ml), and 1 month after LDLLT (433 ± 134 ng/ml), followed by a gradual decline over 1 year. The mean IK values in infections were significantly lower than those in the stable state (119 vs 312 ATP ng/ml, p = 0.0002).
Conclusions: IK values increased sharply after lung transplantation and then decreased gradually over time in the first year, suggesting a natural history of immune function. IK values were also significantly reduced during infections. These results may provide new insights into the utility of immune monitoring after lung transplantation.
Keywords: Adenosine triphosphate production; Immune function test; Lung transplantation; Postoperative infections.
Similar articles
-
"Immuknow" to measurement of cell-mediated immunity in renal transplant recipients undergoing short-term evaluation.Transplant Proc. 2011 May;43(4):1013-6. doi: 10.1016/j.transproceed.2011.02.043. Transplant Proc. 2011. PMID: 21620039
-
Immune function assay (ImmuKnow) as a predictor of allograft rejection and infection in kidney transplantation.Clin Transplant. 2013 Jul-Aug;27(4):E351-8. doi: 10.1111/ctr.12134. Epub 2013 May 20. Clin Transplant. 2013. PMID: 23682828
-
Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection.J Heart Lung Transplant. 2008 Sep;27(9):990-4. doi: 10.1016/j.healun.2008.06.005. J Heart Lung Transplant. 2008. PMID: 18765191
-
Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients.Transpl Immunol. 2016 Jul;37:35-39. doi: 10.1016/j.trim.2016.04.001. Epub 2016 Apr 16. Transpl Immunol. 2016. PMID: 27095000
-
Living lobar lung transplantation.Respir Care Clin N Am. 2004 Dec;10(4):563-79. doi: 10.1016/j.rcc.2004.06.004. Respir Care Clin N Am. 2004. PMID: 15585183 Review.
Cited by
-
Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo:SOT study): a prospective non-interventional observational trial.BMC Infect Dis. 2019 Jul 3;19(1):573. doi: 10.1186/s12879-019-4207-9. BMC Infect Dis. 2019. PMID: 31269923 Free PMC article.
-
Effect of Immunosuppression on Target Blood Immune Cells Within 1 Year After Lung Transplantation: Influence of Age on T Lymphocytes.Ann Transplant. 2018 Jan 5;23:11-24. doi: 10.12659/aot.906372. Ann Transplant. 2018. PMID: 29302022 Free PMC article.
-
Pharmacodynamics monitoring after lung transplantation.JHLT Open. 2025 Feb 27;8:100233. doi: 10.1016/j.jhlto.2025.100233. eCollection 2025 May. JHLT Open. 2025. PMID: 40486112 Free PMC article. Review.
-
Individualizing immunosuppression in lung transplantation.Glob Cardiol Sci Pract. 2018 Mar 14;2018(1):5. doi: 10.21542/gcsp.2018.5. Glob Cardiol Sci Pract. 2018. PMID: 29644232 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical